AVITA Medical RCEL
NASDAQ RCEL
$10.14 -0.20 (-1.93%)
At close: Aug 20, 2026 · 2:20 PM UTC

AVITA Medical (RCEL) Total Non-Current Liabilities (2018 - 2026)

AVITA Medical's (RCEL) quarterly Total Non-Current Liabilities came in at $71.8 million in Q4 2025, little changed YoY from $72.0 million in Q4 2024, and up 4.76% on a QoQ basis from $68.5 million in Q3 2025.

AVITA Medical (RCEL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends

AVITA Medical (RCEL) has 8 years of Total Non-Current Liabilities data on file, last reported at $71.8 million in Q4 2025.

  • Quarterly Total Non-Current Liabilities changed 0.23% year-over-year to $71.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $71.8 million (changed 0.23% YoY) and the FY2025 annual result came in at $71.8 million, changed 0.23% from the prior year.
  • Total Non-Current Liabilities grew to $71.8 million in Q4 2025, from $68.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $72.0 million in Q4 2024 to a low of $8.1 million in Q1 2022.
  • A 5-year average of $41.6 million and a median of $59.3 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities slipped 11.18% — and 2023, when it jumped 405.49%.
  • Tracing RCEL's Total Non-Current Liabilities over 5 years: stood at $11.3 million in 2021, then increased by 3.02% to $11.6 million in 2022, then jumped by 405.49% to $58.7 million in 2023, then climbed by 22.53% to $72.0 million in 2024, then retreated by 0.23% to $71.8 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $71.8 million (Q4 2025), $68.5 million (Q3 2025), and $69.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn -
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 9.07 Bn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn 3.44 Bn
10 AVITA Medical 311.80 Mn 300.67 Mn 17.77 Mn 74.74 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 74.74 Mn
Dec 31, 2025 71.80 Mn
Sep 30, 2025 68.53 Mn
Jun 30, 2025 69.08 Mn
Mar 31, 2025 71.01 Mn
Dec 31, 2024 71.97 Mn
Sep 30, 2024 65.84 Mn
Jun 30, 2024 61.55 Mn
Mar 31, 2024 59.96 Mn
Dec 31, 2023 58.73 Mn
Dec 31, 2022 11.62 Mn
Jun 30, 2022 9.23 Mn
Mar 31, 2022 8.11 Mn
Dec 31, 2021 11.28 Mn
Sep 30, 2021 9.18 Mn
Jun 30, 2021 9.34 Mn
Mar 31, 2021 9.13 Mn
Jun 30, 2020 10.06 Mn
Jun 30, 2019 465,625.64
Jun 30, 2018 101,698.83